{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:20:38Z","timestamp":1772140838701,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Circular RNA (circRNA) is recently found to participate in the regulation of tumor progression, including ovarian cancer. However, the application of circRNA SET domain bifurcated histone lysine methyltransferase 1 (circSETDB1) as a therapeutic target in serous ovarian cancer (SOC) remains to be elucidated. Herein, circSETDB1 role in SOC malignant progression and underlying mechanism are revealed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of circSETDB1, microRNA-129-3p (miR-129-3p) and mitogen-activated protein kinase kinase kinase 3 (MAP3K3) messenger RNA (mRNA) was detected by quantitative real-time polymerase chain reaction. Protein abundance was determined by western blot analysis. Cell proliferation, apoptosis, invasion and migration were demonstrated by cell counting kit-8 and 5-Ethynyl-29-deoxyuridine assays, flow cytometry analysis, transwell invasion assay and wound-healing assay, respectively. The interaction between miR-129-3p and circSETDB1 or MAP3K3 was predicted by online database, and identified by mechanism assays. The effect of circSETDB1 knockdown on tumor formation in vivo was unveiled by mouse model experiment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CircSETDB1 and MAP3K3 expression were apparently upregulated, whereas miR-129-3p expression was downregulated in SOC tissues and cells in comparison with normal fallopian tube tissues or normal ovarian epithelial cells. CircSETDB1 knockdown inhibited cell proliferation, invasion and migration, but induced cell apoptosis in SOC cells. Additionally, miR-129-3p inhibitor impaired circSETDB1 silencing-mediated SOC malignant progression. MiR-129-3p repressed SOC cell processes via binding to MAP3K3. Furthermore, circSETDB1 knockdown suppressed tumor growth in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CircSETDB1 silencing repressed SOC malignant progression through miR-129-3p\/MAP3K3 pathway. This study supports circSETDB1 as a new therapeutic target for SOC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-021-00875-0","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T09:04:58Z","timestamp":1637139898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3"],"prefix":"10.1186","volume":"14","author":[{"given":"Bo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"issue":"40","key":"875_CR1","doi-asserted-by":"publisher","first-page":"14542","DOI":"10.1073\/pnas.1402814111","volume":"111","author":"MG AbouHaidar","year":"2014","unstructured":"AbouHaidar MG, Venkataraman S, Golshani A, Liu B, Ahmad T. Novel coding, translation, and gene expression of a replicating covalently closed circular RNA of 220 nt. Proc Natl Acad Sci USA. 2014;111(40):14542\u20137. https:\/\/doi.org\/10.1073\/pnas.1402814111.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"875_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5.","journal-title":"Cell"},{"issue":"11","key":"875_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell DD, B\u00f6hm S, Ahmed AA, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015;15(11):668\u201379. https:\/\/doi.org\/10.1038\/nrc4019.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"875_CR4","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/jco.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20(5):1248\u201359. https:\/\/doi.org\/10.1200\/jco.2002.20.5.1248.","journal-title":"J Clin Oncol"},{"issue":"2","key":"875_CR5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jcp.29009","volume":"235","author":"S Chaichian","year":"2020","unstructured":"Chaichian S, Shafabakhsh R, Mirhashemi SM, Moazzami B, Asemi Z. Circular RNAs: a novel biomarker for cervical cancer. J Cell Physiol. 2020;235(2):718\u201324. https:\/\/doi.org\/10.1002\/jcp.29009.","journal-title":"J Cell Physiol"},{"issue":"6824","key":"875_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410(6824):37\u201340. https:\/\/doi.org\/10.1038\/35065000.","journal-title":"Nature"},{"issue":"47","key":"875_CR7","doi-asserted-by":"publisher","first-page":"78009","DOI":"10.18632\/oncotarget.12870","volume":"7","author":"S Cui","year":"2016","unstructured":"Cui S, Zhang K, Li C, et al. Methylation-associated silencing of microRNA-129\u20133p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A. Oncotarget. 2016;7(47):78009\u201328. https:\/\/doi.org\/10.18632\/oncotarget.12870.","journal-title":"Oncotarget"},{"issue":"1","key":"875_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13045-016-0370-2","volume":"10","author":"Y Dong","year":"2017","unstructured":"Dong Y, He D, Peng Z, et al. Circular RNAs in cancer: an emerging key player. J Hematol Oncol. 2017;10(1):2\u20132. https:\/\/doi.org\/10.1186\/s13045-016-0370-2.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"875_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s12935-020-01666-1","volume":"20","author":"Z Du","year":"2020","unstructured":"Du Z, Wang L, Xia Y. Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p\/CUL4B pathway. Cancer Cell Int. 2020;20(1):572. https:\/\/doi.org\/10.1186\/s12935-020-01666-1.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"875_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.26355\/eurrev_201802_14387","volume":"22","author":"DZ Fang","year":"2018","unstructured":"Fang DZ, Wang YP, Liu J, et al. MicroRNA-129\u20133p suppresses tumor growth by targeting E2F5 in glioblastoma. Eur Rev Med Pharmacol Sci. 2018;22(4):1044\u201350. https:\/\/doi.org\/10.26355\/eurrev_201802_14387.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"875_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-020-01163-z","volume":"19","author":"X Gan","year":"2020","unstructured":"Gan X, Zhu H, Jiang X, et al. CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a. Mol Cancer. 2020;19(1):45\u201345. https:\/\/doi.org\/10.1186\/s12943-020-01163-z.","journal-title":"Mol Cancer"},{"issue":"2","key":"875_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.5582\/bst.2019.01021","volume":"13","author":"Y Gao","year":"2019","unstructured":"Gao Y, Zhang C, Liu Y, Wang M. Circular RNA profiling reveals circRNA1656 as a novel biomarker in high grade serous ovarian cancer. Biosci Trends. 2019;13(2):204\u201311. https:\/\/doi.org\/10.5582\/bst.2019.01021.","journal-title":"Biosci Trends"},{"issue":"4","key":"875_CR13","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.3892\/ol.2019.10021","volume":"17","author":"Q Guo","year":"2019","unstructured":"Guo Q, He Y, Sun L, et al. In silico detection of potential prognostic circRNAs through a re-annotation strategy in ovarian cancer. Oncol Lett. 2019;17(4):3677\u201386. https:\/\/doi.org\/10.3892\/ol.2019.10021.","journal-title":"Oncol Lett"},{"issue":"7441","key":"875_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384\u20138. https:\/\/doi.org\/10.1038\/nature11993.","journal-title":"Nature"},{"issue":"11","key":"875_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.tig.2019.08.004","volume":"35","author":"JT Hua","year":"2019","unstructured":"Hua JT, Chen S, He HH. Landscape of noncoding RNA in prostate cancer. Trends Genet. 2019;35(11):840\u201351. https:\/\/doi.org\/10.1016\/j.tig.2019.08.004.","journal-title":"Trends Genet"},{"issue":"3","key":"875_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/PPO.0b013e318250c001","volume":"18","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM. Causes and consequences of microRNA dysregulation. Cancer J. 2012;18(3):215\u201322. https:\/\/doi.org\/10.1097\/PPO.0b013e318250c001.","journal-title":"Cancer J"},{"issue":"2","key":"875_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141\u201357. https:\/\/doi.org\/10.1261\/rna.035667.112.","journal-title":"RNA"},{"issue":"1","key":"875_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbrc.2018.02.036","volume":"497","author":"W Ji","year":"2018","unstructured":"Ji W, Qiu C, Wang M, et al. Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer. Biochem Biophys Res Commun. 2018;497(1):122\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.036.","journal-title":"Biochem Biophys Res Commun"},{"key":"875_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.humpath.2015.12.011","volume":"50","author":"W Jia","year":"2016","unstructured":"Jia W, Dong Y, Tao L, et al. MAP3K3 overexpression is associated with poor survival in ovarian carcinoma. Hum Pathol. 2016;50:162\u20139. https:\/\/doi.org\/10.1016\/j.humpath.2015.12.011.","journal-title":"Hum Pathol"},{"issue":"2","key":"875_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3892\/ol.2019.11216","volume":"19","author":"Y Jia","year":"2020","unstructured":"Jia Y, Gao Y, Dou J. Effects of miR-129-3p on biological functions of prostate cancer cells through targeted regulation of Smad3. Oncol Lett. 2020;19(2):1195\u2013202. https:\/\/doi.org\/10.3892\/ol.2019.11216.","journal-title":"Oncol Lett"},{"issue":"5600","key":"875_CR21","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"GL Johnson","year":"2002","unstructured":"Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298(5600):1911\u20132. https:\/\/doi.org\/10.1126\/science.1072682.","journal-title":"Science"},{"key":"875_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"YS Lee","year":"2009","unstructured":"Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199\u2013227. https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.092222.","journal-title":"Annu Rev Pathol"},{"key":"875_CR23","doi-asserted-by":"publisher","first-page":"108832","DOI":"10.1016\/j.biopha.2019.108832","volume":"114","author":"QH Li","year":"2019","unstructured":"Li QH, Liu Y, Chen S, et al. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236\u20133p sponge. Biomed Pharmacother. 2019;114:108832. https:\/\/doi.org\/10.1016\/j.biopha.2019.108832.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"875_CR24","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00018-019-03345-5","volume":"77","author":"R Li","year":"2020","unstructured":"Li R, Jiang J, Shi H, et al. CircRNA: a rising star in gastric cancer. Cell Mol Life Sci. 2020;77(9):1661\u201380. https:\/\/doi.org\/10.1007\/s00018-019-03345-5.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"875_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13073-019-0629-7","volume":"11","author":"S Li","year":"2019","unstructured":"Li S, Han L. Circular RNAs as promising biomarkers in cancer: detection, function, and beyond. Genome Med. 2019;11(1):15. https:\/\/doi.org\/10.1186\/s13073-019-0629-7.","journal-title":"Genome Med"},{"issue":"4","key":"875_CR26","doi-asserted-by":"publisher","first-page":"e0214822","DOI":"10.1371\/journal.pone.0214822","volume":"14","author":"T Li","year":"2019","unstructured":"Li T, Zhou W, Li Y, et al. MiR-4524b-5p\/WTX\/\u03b2-catenin axis functions as a regulator of metastasis in cervical cancer. PLoS One. 2019;14(4):e0214822-e214922. https:\/\/doi.org\/10.1371\/journal.pone.0214822.","journal-title":"PLoS One"},{"key":"875_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12935-019-1071-z","volume":"20","author":"W Lin","year":"2020","unstructured":"Lin W, Ye H, You K, Chen L. Up-regulation of circ_LARP4 suppresses cell proliferation and migration in ovarian cancer by regulating miR-513b-5p\/LARP4 axis. Cancer Cell Int. 2020;20:5. https:\/\/doi.org\/10.1186\/s12935-019-1071-z.","journal-title":"Cancer Cell Int"},{"issue":"12","key":"875_CR28","first-page":"5901","volume":"11","author":"F Liu","year":"2018","unstructured":"Liu F, Zhao H, Gong L, et al. MicroRNA-129-3p functions as a tumor suppressor in serous ovarian cancer by targeting BZW1. Int J Clin Exp Pathol. 2018;11(12):5901\u20138.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"875_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","volume":"16","author":"S Meng","year":"2017","unstructured":"Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94. https:\/\/doi.org\/10.1186\/s12943-017-0663-2.","journal-title":"Mol Cancer"},{"key":"875_CR30","doi-asserted-by":"publisher","first-page":"102854","DOI":"10.1016\/j.critrevonc.2019.102854","volume":"145","author":"P Naeli","year":"2020","unstructured":"Naeli P, Pourhanifeh MH, Karimzadeh MR, et al. Circular RNAs and gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol. 2020;145:102854. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.102854.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"17","key":"875_CR31","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1002\/cncr.24445","volume":"115","author":"AK Samanta","year":"2009","unstructured":"Samanta AK, Huang HJ, Le X-F, et al. MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma. Cancer. 2009;115(17):3897\u2013908. https:\/\/doi.org\/10.1002\/cncr.24445.","journal-title":"Cancer"},{"issue":"4","key":"875_CR32","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.21873\/anticanres.12431","volume":"38","author":"R Santoro","year":"2018","unstructured":"Santoro R, Zanotto M, Carbone C, et al. MEKK3 sustains EMT and stemness in pancreatic cancer by regulating YAP and TAZ transcriptional activity. Anticancer Res. 2018;38(4):1937\u201346. https:\/\/doi.org\/10.21873\/anticanres.12431.","journal-title":"Anticancer Res"},{"issue":"1","key":"875_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13048-019-0558-5","volume":"12","author":"Z Shabaninejad","year":"2019","unstructured":"Shabaninejad Z, Vafadar A, Movahedpour A, et al. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. J Ovarian Res. 2019;12(1):84\u201384. https:\/\/doi.org\/10.1186\/s13048-019-0558-5.","journal-title":"J Ovarian Res"},{"issue":"1","key":"875_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590.","journal-title":"CA Cancer J Clin"},{"key":"875_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biocel.2019.04.011","volume":"112","author":"F Teng","year":"2019","unstructured":"Teng F, Xu J, Zhang M, et al. Comprehensive circular RNA expression profiles and the tumor-suppressive function of circHIPK3 in ovarian cancer. Int J Biochem Cell Biol. 2019;112:8\u201317. https:\/\/doi.org\/10.1016\/j.biocel.2019.04.011.","journal-title":"Int J Biochem Cell Biol"},{"key":"875_CR36","doi-asserted-by":"publisher","first-page":"7451","DOI":"10.2147\/OTT.S220700","volume":"12","author":"W Wang","year":"2019","unstructured":"Wang W, Wang J, Zhang X, Liu G. Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer. Onco Targets Ther. 2019;12:7451\u20137. https:\/\/doi.org\/10.2147\/OTT.S220700.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"875_CR37","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1111\/jcmm.14260","volume":"23","author":"J Xie","year":"2019","unstructured":"Xie J, Wang S, Li G, et al. circEPSTI1 regulates ovarian cancer progression via decoying miR-942. J Cell Mol Med. 2019;23(5):3597\u2013602. https:\/\/doi.org\/10.1111\/jcmm.14260.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"875_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/2211-5463.12545","volume":"9","author":"W Yin","year":"2019","unstructured":"Yin W, Shi L, Mao Y. MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression. FEBS Open Bio. 2019;9(1):43\u201352. https:\/\/doi.org\/10.1002\/2211-5463.12545.","journal-title":"FEBS Open Bio"},{"issue":"10","key":"875_CR39","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1002\/cam4.2929","volume":"9","author":"C Zhang","year":"2020","unstructured":"Zhang C, Li Y, Zhao W, Liu G, Yang Q. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p\/CDC5L\/PEAK1 pathway. Cancer Med. 2020;9(10):3500\u201321. https:\/\/doi.org\/10.1002\/cam4.2929.","journal-title":"Cancer Med"},{"issue":"3","key":"875_CR40","first-page":"875","volume":"12","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhang Y, Wang S, et al. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3. Am J Transl Res. 2020;12(3):875\u201388.","journal-title":"Am J Transl Res"},{"issue":"1","key":"875_CR41","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1080\/21691401.2019.1593999","volume":"47","author":"M Zhang","year":"2019","unstructured":"Zhang M, Xia B, Xu Y, et al. Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637\/KLK4 axis. Artif Cells Nanomed Biotechnol. 2019;47(1):1224\u201333. https:\/\/doi.org\/10.1080\/21691401.2019.1593999.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"4","key":"875_CR42","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1021\/acs.molpharmaceut.8b00071","volume":"15","author":"L Zhao","year":"2018","unstructured":"Zhao L, Ni X, Zhao L, et al. MiroRNA-188 acts as tumor suppressor in non-small-cell lung cancer by targeting MAP3K3. Mol Pharm. 2018;15(4):1682\u20139. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00071.","journal-title":"Mol Pharm"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00875-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-021-00875-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00875-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T09:13:39Z","timestamp":1637140419000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-021-00875-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1186\/s13048-021-00875-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the ethical review committee of Yantaishan hospital. Written informed consent was obtained from all enrolled patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients agree to participate in this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}